Non-steroidal mineralocorticoid receptor antagonists in heart failure

被引：2
|
作者：
Filippatos, Gerasimos [1 ]
Farmakis, Dimitrios [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Athens Univ Hosp Attikon, Dept Cardiol, Med Sch, Athens, Greece
来源：
NATURE REVIEWS CARDIOLOGY | 2023年 / 20卷 / 10期
关键词：
CHRONIC KIDNEY-DISEASE; FINERENONE;
D O I：
10.1038/s41569-023-00922-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Novel non-steroidal mineralocorticoid receptor antagonists (MRAs) have improved pharmacological properties compared with steroidal MRAs. Among the non-steroidal MRAs, finerenone has been approved for patients with chronic kidney disease who have diabetes mellitus and has demonstrated favourable safety and promising early results in patients with heart failure.
引用
收藏
页码：645 / 646
页数：2
相关论文
共 50 条
  • [1] Non-steroidal mineralocorticoid receptor antagonists in heart failure
    Filippatos, Gerasimos
    Farmakis, Dimitrios
    [J]. NATURE REVIEWS CARDIOLOGY, 2023,
  • [2] Non-steroidal mineralocorticoid receptor antagonists
    Meyers, Marvin J.
    Hu, Xiao
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (01) : 17 - 23
  • [3] Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
    Agarwal, Rajiv
    Kolkhof, Peter
    Bakris, George
    Bauersachs, Johann
    Haller, Hermann
    Wada, Takashi
    Zannad, Faiez
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (02) : 152 - 161
  • [4] Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease
    Pandey, Arjun K.
    Bhatt, Deepak L.
    Cosentino, Francesco
    Marx, Nikolaus
    Rotstein, Ori
    Pitt, Bertram
    Pandey, Ambirash
    Butler, Javed
    Verma, Subodh
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 (31) : 2931 - 2945
  • [5] Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
    Savarese, Gianluigi
    Lindberg, Felix
    Filippatos, Gerasimos
    Butler, Javed
    Anker, Stefan D.
    [J]. DIABETOLOGIA, 2024, 67 (02) : 246 - 262
  • [6] Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
    Gianluigi Savarese
    Felix Lindberg
    Gerasimos Filippatos
    Javed Butler
    Stefan D. Anker
    [J]. Diabetologia, 2024, 67 : 246 - 262
  • [7] Novel non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease
    Kintscher, Ulrich
    Bakris, George L.
    Kolkhof, Peter
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (13) : 3220 - 3234
  • [8] Potential Impact of Non-Steroidal Mineralocorticoid Receptor Antagonists in Cardiovascular Disease
    Rahman, Asadur
    Jahan, Nourin
    Rahman, Md Tanvir
    Nishiyama, Akira
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [9] Discovery of novel non-steroidal reverse indole mineralocorticoid receptor antagonists
    Ogawa, Anthony K.
    Bunte, Ellen Vande
    Mal, Rudrajit
    Lan, Ping
    Sun, Zhongxiang
    Crespo, Alejandro
    Wiltsie, Judyann
    Clemas, Joseph
    Gibson, Jack
    Contino, Lisa
    Lisnock, JeanMarie
    Zhou, Gaochao
    Garcia-Calvo, Margarita
    Jochnowitz, Nina
    Ma, Xiuying
    Pan, Yi
    Brown, Patricia
    Zamlynny, Beata
    Bateman, Thomas
    Leung, Dennis
    Xu, Ling
    Tong, Xinchun
    Liu, Kun
    Crook, Martin
    Sinclair, Peter
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (12) : 2866 - 2869
  • [10] Discovery of potent, selective, non-steroidal mineralocorticoid receptor antagonists.
    Neel, DA
    Brown, ML
    Lander, PA
    Grese, TA
    Defauw, JM
    Doti, RA
    Fields, T
    Smith, S
    Wiest, SA
    Zimmerman, KM
    Steinberg, MI
    Jadhav, PK
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U46 - U46
12345